logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

Valesca P. Retèl

department of psychosocial research and epidemiology
H指数:28
被引数:3,700

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial

靶向同源重组缺陷：高强度化疗与标准化疗联合奥拉帕尼治疗III期乳腺癌的疗效比较（SUBITO研究）：一项开放标签、随机对照、III期临床试验

Lancet Oncology
IF35.9
2026-06-290
PRE
Rianne L Seefat; Sonja B Vliek; Vincent M T de Jong; Sara Balduzzi; Ingrid A Mandjes; Valesca P Retèl; Inge Eekhout; Marjolein Delfos; Margaret Schot; Marjo J Holtkamp; Mandy M van Rosmalen; Brenda Leeneman; Hedwig Blommestein; Alwin D R Huitema; Efraim H Rosenberg; Petra M Nederlof; Terry W S Chan; Anna van Rhenen; Marielle J Wondergem; Nicolaas P M Schaap
Human Epididymis protein 4 and Risk of Malignancy Index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch healthcare perspective

人绒毛膜蛋白4和恶性风险指数作为卵巢肿块患者转诊至肿瘤中心的决策风险评估工具：基于荷兰医疗保健视角的成本效益分析

International Journal of Gynecological Cancer
IF4.7
2026-04-220
PRE
Pien Lof; Simone N. Koole; Anna Stiekema; Myrthe Jansen; Guus Fons; Frédéric Amant; Mignon D.J.M van Gent; Constantijne H. Mom; Fleur M.F. Rosier-van Dunné; Wilhelmina M. van Baal; Harold R. Verhoeve; Brenda B.J. Hermsen; Marjolijn B. Verbruggen; Majoie Hemelaar; Jojanneke M.G. van de Swaluw; Haye C. Knipscheer; Judith A.F. Huirne; Steven M. Westenberg; Valesca P. Retèl; Daan van den Broek
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial

新辅助伊匹木单抗和纳武利尤单抗在可切除皮肤鳞状细胞癌中的应用：一项随机Ⅱ期临床试验

Nature Medicine
IF50
2025-10-080
OAAI
Sabine E. Breukers; Joleen J. H. Traets; Stan W. van Dijk; Mercedes Machuca Ostos; Itske Fraterman; Robert D. Crommelin; Hedda van der Hulst; Xiaohang Qiao; Thomas Boere; Lonneke V. van de Poll-Franse; Valesca Retèl; Vincent van der Noort; Joris L. Vos; Alexandra G. L. Toppenberg; Martijn van der Heijden; Francesco Missale; Fons Balm; Michiel van den Brekel; Richard Dirven; M. Baris Karakullukcu; Luc Karssemakers; W. Martin C. Klop; Peter J.F.M Lohuis; Willem H. Schreuder; Ludi E. Smeele; Lilly-Ann van der Velden; Elsemieke Plasmeijer; Laura A. Smit; Jan Paul de Boer; Arash Navran; Bram Westerink; Petra K. de Koekkoek-Doll; Jonas Castelijns; Maurits Wondergem; Wouter V. Vogel; Anke Kuijpers; Winan J. van Houdt; Suzanne Onderwater; Esther Maas-Bannink; Sten Cornelissen; Annegien Broeks; Bernard M. Tijink; Lot A. Devriese; Remco de Bree; Christian U. Blank; Ton N. Schumacher; Daniela S. Thommen; John B.A.G. Haanen; Charlotte L. Zuur
Health-Related Quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared to ipilimumab in a randomized phase 3 trial

与健康相关的生活质量：比较接受肿瘤浸润淋巴细胞治疗的转移性黑色素瘤患者与接受ipilimumab治疗的随机III期试验

Annals of Oncology
IF65.4
2025-06-180
PREAI
R.M.T. ten Ham; M.W. Rohaan; M. Egeler; R. Menezes; T. Holz Borch; R. Kessels; I. Jedema; B. Nuijen; C.M. Nijenhuis; L.V. van de Poll-Franse; M.H. Geukes Foppen; M. Lindenberg; I. Mansfield Noringriis; T.J. Monberg; M. Donia; W. van Harten; I.M. Svane; J.B.A.G. Haanen; V.P. Retèl
Financial toxicity and socioeconomic impact of cancer in Europe

癌症在欧洲的财务毒性和社会经济影响

ESMO Open
IF8.3
2025-06-010
OA
J. Vancoppenolle; N. Franzen; L. Azarang; T. Juslin; M. Krini; T. Lubbers; J. Mattson; D. Mayeur; R. Menezes; J. Schmitt; F. Scotte; O. Seoane López; T. Skaali; J. Ubels; M. Schlander; V. Retel; W.H. van Harten
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

ctDNA指导的 ⅱ 期结肠癌辅助化疗选择的有效性和成本-效果的早期评价

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-08-212
OAAI
Kramer, Astrid; Greuter, Marjolein J. E.; Schraa, Suzanna J.; Vink, Geraldine R.; Phallen, Jillian; Velculescu, Victor E.; Meijer, Gerrit A.; van den Broek, Daan; Koopman, Miriam; Roodhart, Jeanine M. L.; Fijneman, Remond J. A.; Retel, Valesca P.; Coupe, Veerle M. H.
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

多组学分析将低白蛋白血症确定为转移性黑色素瘤PD-1阻断后不良预后的独立生物标志物

SCIENTIFIC REPORTS
IF3.9
2024-05-164
OAAI
Leek, Lindsay V. M.; Notohardjo, Jessica C. L.; de Joode, Karlijn; Velker, Eline L.; Haanen, John B. A. G.; Suijkerbuijk, Karijn P. M.; Aarts, Maureen J. B.; de Groot, Jan Willem B.; Kapiteijn, Ellen; van den Berkmortel, Franchette W. P. J.; Westgeest, Hans M.; de Gruijl, Tanja D.; Retel, Valesca P.; Cuppen, Edwin; van der Veldt, Astrid A. M.; Labots, Mariette; Voest, Emile E.; van de Haar, Joris; van den Eertwegh, Alfons J. M.

研究方向

暂未获取到该数据
W
Wim H. van Harten
H 指数:45论文数:319被引数:8,655
S
Sabine C. Linn
H 指数:65论文数:631被引数:1.7万
M
Melanie Lindenberg
H 指数:10论文数:19被引数:305
M
Manuela Joore
H 指数:50论文数:366被引数:8,314
J
John B.A.G. Haanen
H 指数:109论文数:931被引数:9.8万
E
Emiel J. Rutgers
H 指数:97论文数:776被引数:5.4万
L
Lotte Steuten
H 指数:33论文数:214被引数:4,120
J
Jelle Wesseling
H 指数:73论文数:650被引数:2.2万
H
Harm van Tinteren
H 指数:90论文数:584被引数:3.3万
V
Veerle M.H. Coupé
H 指数:43论文数:365被引数:6,233